Share Price and Basic Stock Data
Last Updated: January 24, 2026, 4:20 pm
| PEG Ratio | 0.19 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Mawana Sugars Ltd operates in the sugar industry and reported a market capitalization of ₹313 Cr. The company’s stock price stood at ₹80.1, showing a P/E ratio of 6.11, which is relatively low compared to industry averages, indicating potential undervaluation. Revenue from operations for the trailing twelve months reached ₹1,507 Cr, reflecting a modest growth trajectory. The quarterly sales figures demonstrated variability, with the highest sales of ₹482 Cr recorded in December 2022, while the most recent quarter (September 2023) saw sales of ₹381 Cr. The company’s total sales for FY 2025 were reported at ₹1,446 Cr, a slight increase from ₹1,355 Cr in FY 2024, indicating resilience amidst a challenging market environment. The fluctuating sales numbers may suggest seasonal impacts or operational challenges faced by the company in maintaining consistent revenue streams.
Profitability and Efficiency Metrics
Mawana Sugars reported a net profit of ₹105 Cr, translating to a net profit margin of 7.56% for FY 2025. The operating profit margin (OPM) was notably low at -2%, reflecting operational inefficiencies. The company demonstrated a return on equity (ROE) of 12.8% and return on capital employed (ROCE) of 10.3%, which are reasonable compared to typical sector benchmarks. However, the operating profit fluctuated significantly across quarters, with the highest operating profit of ₹81 Cr recorded in March 2023. The significant quarterly losses, particularly the -₹29 Cr operating loss in September 2023, highlight challenges in cost management. The interest coverage ratio, which stood at 4.44x, suggests that the company is managing its interest obligations adequately, although the negative OPM raises concerns about ongoing profitability sustainability.
Balance Sheet Strength and Financial Ratios
The balance sheet of Mawana Sugars reveals total assets of ₹1,096 Cr, with total liabilities recorded at ₹1,096 Cr as well, indicating a balanced state between assets and liabilities. The company’s reserves have improved significantly from negative ₹245 Cr in September 2013 to ₹453 Cr by March 2025. Borrowings have decreased dramatically to ₹8 Cr from a previous high of ₹702 Cr in September 2013, indicating a strong reduction in debt levels. The current ratio stood at 1.50, suggesting a healthy liquidity position, while the quick ratio of 0.11 indicates challenges in meeting immediate liabilities. The price-to-book value ratio of 0.68x implies that the stock is trading at a discount to its book value, which could attract value investors. However, the company’s cash conversion cycle of 231 days suggests inefficiencies in working capital management, potentially impacting liquidity.
Shareholding Pattern and Investor Confidence
Mawana Sugars has a concentrated shareholding structure, with promoters holding 63.49% of the total equity. The foreign institutional investors (FIIs) hold a minor stake of 0.58%, while domestic institutional investors (DIIs) have a negligible 0.07% stake. The public holds 35.86% of shares, which includes a gradual decline in the number of shareholders from 56,955 in December 2022 to 56,113 in September 2025. This trend may reflect a lack of confidence among retail investors, possibly due to the company’s inconsistent profitability and operational challenges. While the stable promoter holding indicates commitment, the low institutional interest may raise concerns about the stock’s growth prospects. The dividend payout ratio has varied significantly, standing at 25.02% for FY 2025, reflecting a cautious approach towards sharing profits with shareholders, given the operational challenges faced by the company.
Outlook, Risks, and Final Insight
The outlook for Mawana Sugars hinges on its ability to stabilize profitability and improve operational efficiency. The company faces risks from fluctuating sugar prices, which can impact revenue adversely, as evidenced by the inconsistent quarterly sales. Additionally, the operational challenges reflected in the negative OPM and high cash conversion cycle indicate potential liquidity issues that could hinder growth. On the positive side, the significant reduction in borrowings and improved reserves suggest a stronger financial footing. If Mawana Sugars can leverage its assets effectively and improve its cost management practices, it may enhance profitability and investor confidence. However, any further decline in profitability could lead to increased scrutiny from investors, necessitating a robust strategic response to ensure sustainable growth in a competitive market.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gayatri Sugars Ltd | 68.6 Cr. | 9.23 | 16.7/7.02 | 245 | 16.8 | 0.00 % | 36.6 % | % | 10.0 |
| Dhampure Speciality Sugars Ltd | 83.7 Cr. | 95.8 | 115/82.0 | 21.2 | 45.3 | 0.00 % | 11.6 % | 8.88 % | 10.0 |
| Dhampur Bio Organics Ltd | 636 Cr. | 95.8 | 105/57.3 | 26.8 | 145 | 1.31 % | 3.97 % | 1.56 % | 10.0 |
| DCM Shriram Industries Ltd | 511 Cr. | 39.2 | 63.1/38.8 | 8.39 | 105 | 5.11 % | 13.7 % | 11.8 % | 2.00 |
| Davangere Sugar Company Ltd | 671 Cr. | 4.69 | 11.9/3.03 | 53.1 | 3.52 | 0.00 % | 6.70 % | 3.17 % | 1.00 |
| Industry Average | 1,670.88 Cr | 246.63 | 28.99 | 225.56 | 0.88% | 8.62% | 7.89% | 6.37 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 341 | 482 | 350 | 326 | 381 | 326 | 322 | 387 | 382 | 334 | 343 | 401 | 429 |
| Expenses | 368 | 462 | 269 | 330 | 409 | 285 | 241 | 372 | 393 | 305 | 254 | 401 | 439 |
| Operating Profit | -27 | 19 | 81 | -3 | -29 | 41 | 81 | 15 | -10 | 29 | 89 | -1 | -10 |
| OPM % | -8% | 4% | 23% | -1% | -8% | 13% | 25% | 4% | -3% | 9% | 26% | -0% | -2% |
| Other Income | 1 | 1 | 0 | 1 | 26 | 0 | 1 | 1 | 0 | 64 | 5 | 1 | 0 |
| Interest | 9 | 4 | 6 | 10 | 7 | 3 | 10 | 13 | 8 | 1 | 7 | 11 | 4 |
| Depreciation | 8 | 9 | 9 | 8 | 8 | 9 | 10 | 8 | 8 | 9 | 9 | 7 | 7 |
| Profit before tax | -43 | 7 | 66 | -20 | -18 | 29 | 63 | -6 | -27 | 83 | 78 | -18 | -22 |
| Tax % | -24% | 26% | 21% | -24% | -38% | 39% | 25% | -21% | -24% | 13% | 21% | -25% | -25% |
| Net Profit | -32 | 5 | 52 | -16 | -11 | 18 | 47 | -5 | -20 | 73 | 62 | -14 | -16 |
| EPS in Rs | -8.29 | 1.36 | 13.33 | -3.99 | -2.92 | 4.50 | 12.04 | -1.17 | -5.16 | 18.54 | 15.77 | -3.46 | -4.12 |
Last Updated: December 30, 2025, 12:37 am
Below is a detailed analysis of the quarterly data for Mawana Sugars Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 429.00 Cr.. The value appears strong and on an upward trend. It has increased from 401.00 Cr. (Jun 2025) to 429.00 Cr., marking an increase of 28.00 Cr..
- For Expenses, as of Sep 2025, the value is 439.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 401.00 Cr. (Jun 2025) to 439.00 Cr., marking an increase of 38.00 Cr..
- For Operating Profit, as of Sep 2025, the value is -10.00 Cr.. The value appears to be declining and may need further review. It has decreased from -1.00 Cr. (Jun 2025) to -10.00 Cr., marking a decrease of 9.00 Cr..
- For OPM %, as of Sep 2025, the value is -2.00%. The value appears to be declining and may need further review. It has decreased from 0.00% (Jun 2025) to -2.00%, marking a decrease of 2.00%.
- For Other Income, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Jun 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 4.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11.00 Cr. (Jun 2025) to 4.00 Cr., marking a decrease of 7.00 Cr..
- For Depreciation, as of Sep 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 7.00 Cr..
- For Profit before tax, as of Sep 2025, the value is -22.00 Cr.. The value appears to be declining and may need further review. It has decreased from -18.00 Cr. (Jun 2025) to -22.00 Cr., marking a decrease of 4.00 Cr..
- For Tax %, as of Sep 2025, the value is -25.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded -25.00%.
- For Net Profit, as of Sep 2025, the value is -16.00 Cr.. The value appears to be declining and may need further review. It has decreased from -14.00 Cr. (Jun 2025) to -16.00 Cr., marking a decrease of 2.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is -4.12. The value appears to be declining and may need further review. It has decreased from -3.46 (Jun 2025) to -4.12, marking a decrease of 0.66.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:59 am
| Metric | Sep 2013 | Dec 2014n n 15m | Mar 2016n n 15m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,342 | 1,399 | 1,485 | 1,191 | 1,344 | 1,165 | 1,161 | 1,469 | 1,478 | 1,482 | 1,355 | 1,446 | 1,507 |
| Expenses | 1,398 | 1,452 | 1,379 | 1,022 | 1,301 | 1,050 | 1,109 | 1,372 | 1,373 | 1,405 | 1,265 | 1,324 | 1,400 |
| Operating Profit | -57 | -52 | 106 | 169 | 43 | 115 | 52 | 96 | 105 | 77 | 90 | 122 | 107 |
| OPM % | -4% | -4% | 7% | 14% | 3% | 10% | 4% | 7% | 7% | 5% | 7% | 8% | 7% |
| Other Income | 30 | 9 | 10 | 356 | 27 | 11 | 17 | 92 | -2 | 2 | 28 | 70 | 70 |
| Interest | 91 | 77 | 77 | 51 | 38 | 24 | 27 | 35 | 26 | 28 | 30 | 30 | 24 |
| Depreciation | 50 | 61 | 38 | 30 | 24 | 33 | 56 | 48 | 40 | 36 | 35 | 34 | 32 |
| Profit before tax | -168 | -181 | 1 | 443 | 7 | 69 | -13 | 105 | 38 | 15 | 53 | 129 | 122 |
| Tax % | 1% | 0% | 0% | 19% | -33% | 41% | 521% | 31% | 31% | 14% | 29% | 15% | |
| Net Profit | -170 | -181 | 1 | 359 | 10 | 40 | -83 | 73 | 26 | 13 | 38 | 109 | 105 |
| EPS in Rs | -43.15 | -46.37 | 0.20 | 91.78 | 2.49 | 10.32 | -21.19 | 18.73 | 6.69 | 3.36 | 9.62 | 27.97 | 26.73 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 16% | 45% | 89% | 42% | 14% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -97.21% | 300.00% | -307.50% | 187.95% | -64.38% | -50.00% | 192.31% | 186.84% |
| Change in YoY Net Profit Growth (%) | 0.00% | 397.21% | -607.50% | 495.45% | -252.34% | 14.38% | 242.31% | -5.47% |
Mawana Sugars Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 5% |
| 3 Years: | -1% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 22% |
| 3 Years: | 24% |
| TTM: | -3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 27% |
| 3 Years: | 2% |
| 1 Year: | -25% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | 8% |
| Last Year: | 13% |
Last Updated: Unknown
Balance Sheet
Last Updated: December 4, 2025, 1:38 am
| Month | Sep 2013 | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 39 | 39 | 39 | 39 | 39 | 39 | 39 | 39 | 39 | 39 | 39 | 39 | 39 |
| Reserves | -245 | -427 | -426 | 292 | 302 | 342 | 257 | 331 | 345 | 345 | 371 | 453 | 419 |
| Borrowings | 702 | 504 | 482 | 244 | 143 | 239 | 488 | 276 | 417 | 383 | 568 | 419 | 8 |
| Other Liabilities | 394 | 818 | 958 | 588 | 622 | 788 | 689 | 735 | 250 | 266 | 200 | 185 | 100 |
| Total Liabilities | 890 | 934 | 1,053 | 1,163 | 1,105 | 1,408 | 1,474 | 1,380 | 1,051 | 1,033 | 1,179 | 1,096 | 567 |
| Fixed Assets | 529 | 474 | 441 | 321 | 313 | 296 | 298 | 232 | 212 | 197 | 204 | 198 | 178 |
| CWIP | 1 | 1 | 3 | 4 | 8 | 8 | 1 | 13 | 3 | 16 | 1 | 0 | 22 |
| Investments | 0 | 0 | 0 | 0 | 0 | 15 | 13 | 10 | 4 | 3 | 3 | 0 | 0 |
| Other Assets | 360 | 460 | 609 | 838 | 784 | 1,089 | 1,161 | 1,126 | 832 | 817 | 972 | 897 | 366 |
| Total Assets | 890 | 934 | 1,053 | 1,163 | 1,105 | 1,408 | 1,474 | 1,380 | 1,051 | 1,033 | 1,179 | 1,096 | 567 |
Below is a detailed analysis of the balance sheet data for Mawana Sugars Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 39.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 39.00 Cr..
- For Reserves, as of Sep 2025, the value is 419.00 Cr.. The value appears to be declining and may need further review. It has decreased from 453.00 Cr. (Mar 2025) to 419.00 Cr., marking a decrease of 34.00 Cr..
- For Borrowings, as of Sep 2025, the value is 8.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 419.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 411.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 100.00 Cr.. The value appears to be improving (decreasing). It has decreased from 185.00 Cr. (Mar 2025) to 100.00 Cr., marking a decrease of 85.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 567.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,096.00 Cr. (Mar 2025) to 567.00 Cr., marking a decrease of 529.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 178.00 Cr.. The value appears to be declining and may need further review. It has decreased from 198.00 Cr. (Mar 2025) to 178.00 Cr., marking a decrease of 20.00 Cr..
- For CWIP, as of Sep 2025, the value is 22.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 22.00 Cr., marking an increase of 22.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 366.00 Cr.. The value appears to be declining and may need further review. It has decreased from 897.00 Cr. (Mar 2025) to 366.00 Cr., marking a decrease of 531.00 Cr..
- For Total Assets, as of Sep 2025, the value is 567.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,096.00 Cr. (Mar 2025) to 567.00 Cr., marking a decrease of 529.00 Cr..
Notably, the Reserves (419.00 Cr.) exceed the Borrowings (8.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Sep 2013 | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Dec 2014n n 15m | Mar 2016n n 15m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -52.00 | 106.00 | -75.00 | -100.00 | -124.00 | -436.00 | -180.00 | -312.00 | -306.00 | -478.00 | -297.00 | -759.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Sep 2013 | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11 | 13 | 18 | 13 | 14 | 12 | 15 | 10 | 10 | 8 | 11 | 8 |
| Inventory Days | 90 | 108 | 165 | 238 | 176 | 417 | 333 | 246 | 214 | 208 | 300 | 266 |
| Days Payable | 107 | 225 | 268 | 217 | 204 | 355 | 231 | 201 | 57 | 61 | 52 | 44 |
| Cash Conversion Cycle | -5 | -104 | -85 | 34 | -14 | 74 | 117 | 55 | 167 | 155 | 259 | 231 |
| Working Capital Days | -165 | -211 | -142 | -18 | -30 | 9 | 14 | 14 | 34 | 26 | 46 | 69 |
| ROCE % | -19% | -34% | 73% | 44% | 6% | 17% | 2% | 7% | 10% | 6% | 7% | 10% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 27.97 | 9.63 | 3.36 | 6.69 | 18.73 |
| Diluted EPS (Rs.) | 27.97 | 9.63 | 3.36 | 6.69 | 18.73 |
| Cash EPS (Rs.) | 36.56 | 18.70 | 12.55 | 16.51 | 30.98 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 125.75 | 104.87 | 98.24 | 98.24 | 94.51 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 125.75 | 104.87 | 98.24 | 98.24 | 94.51 |
| Revenue From Operations / Share (Rs.) | 369.76 | 346.39 | 378.76 | 377.88 | 375.53 |
| PBDIT / Share (Rs.) | 33.55 | 30.22 | 20.55 | 27.77 | 25.55 |
| PBIT / Share (Rs.) | 24.97 | 21.19 | 11.44 | 17.63 | 13.39 |
| PBT / Share (Rs.) | 33.08 | 13.60 | 3.98 | 9.37 | 32.64 |
| Net Profit / Share (Rs.) | 27.98 | 9.66 | 3.44 | 6.37 | 18.82 |
| NP After MI And SOA / Share (Rs.) | 27.97 | 9.62 | 3.36 | 6.68 | 18.73 |
| PBDIT Margin (%) | 9.07 | 8.72 | 5.42 | 7.34 | 6.80 |
| PBIT Margin (%) | 6.75 | 6.11 | 3.02 | 4.66 | 3.56 |
| PBT Margin (%) | 8.94 | 3.92 | 1.05 | 2.47 | 8.69 |
| Net Profit Margin (%) | 7.56 | 2.78 | 0.90 | 1.68 | 5.01 |
| NP After MI And SOA Margin (%) | 7.56 | 2.77 | 0.88 | 1.76 | 4.98 |
| Return on Networth / Equity (%) | 22.24 | 9.17 | 3.41 | 6.80 | 19.81 |
| Return on Capital Employeed (%) | 19.42 | 19.73 | 11.12 | 15.82 | 11.41 |
| Return On Assets (%) | 9.98 | 3.19 | 1.27 | 2.48 | 5.30 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.10 | 0.20 |
| Total Debt / Equity (X) | 0.84 | 1.38 | 0.99 | 1.08 | 0.66 |
| Asset Turnover Ratio (%) | 1.27 | 1.23 | 1.42 | 1.20 | 1.02 |
| Current Ratio (X) | 1.50 | 1.26 | 1.23 | 1.30 | 1.17 |
| Quick Ratio (X) | 0.11 | 0.10 | 0.14 | 0.15 | 0.29 |
| Inventory Turnover Ratio (X) | 1.70 | 1.59 | 1.71 | 1.49 | 1.43 |
| Dividend Payout Ratio (NP) (%) | 25.02 | 31.15 | 89.33 | 44.87 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 19.14 | 16.06 | 24.05 | 17.82 | 0.00 |
| Earning Retention Ratio (%) | 74.98 | 68.85 | 10.67 | 55.13 | 0.00 |
| Cash Earning Retention Ratio (%) | 80.86 | 83.94 | 75.95 | 82.18 | 0.00 |
| Interest Coverage Ratio (X) | 4.44 | 3.98 | 2.88 | 4.22 | 2.83 |
| Interest Coverage Ratio (Post Tax) (X) | 2.63 | 2.27 | 1.53 | 2.22 | 0.56 |
| Enterprise Value (Cr.) | 732.52 | 872.85 | 698.20 | 890.78 | 288.33 |
| EV / Net Operating Revenue (X) | 0.50 | 0.64 | 0.47 | 0.60 | 0.19 |
| EV / EBITDA (X) | 5.58 | 7.38 | 8.69 | 8.20 | 2.88 |
| MarketCap / Net Operating Revenue (X) | 0.23 | 0.24 | 0.23 | 0.35 | 0.09 |
| Retention Ratios (%) | 74.97 | 68.84 | 10.66 | 55.12 | 0.00 |
| Price / BV (X) | 0.68 | 0.80 | 0.92 | 1.36 | 0.38 |
| Price / Net Operating Revenue (X) | 0.23 | 0.24 | 0.23 | 0.35 | 0.09 |
| EarningsYield | 0.32 | 0.11 | 0.03 | 0.05 | 0.51 |
After reviewing the key financial ratios for Mawana Sugars Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 27.97. This value is within the healthy range. It has increased from 9.63 (Mar 24) to 27.97, marking an increase of 18.34.
- For Diluted EPS (Rs.), as of Mar 25, the value is 27.97. This value is within the healthy range. It has increased from 9.63 (Mar 24) to 27.97, marking an increase of 18.34.
- For Cash EPS (Rs.), as of Mar 25, the value is 36.56. This value is within the healthy range. It has increased from 18.70 (Mar 24) to 36.56, marking an increase of 17.86.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 125.75. It has increased from 104.87 (Mar 24) to 125.75, marking an increase of 20.88.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 125.75. It has increased from 104.87 (Mar 24) to 125.75, marking an increase of 20.88.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 369.76. It has increased from 346.39 (Mar 24) to 369.76, marking an increase of 23.37.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 33.55. This value is within the healthy range. It has increased from 30.22 (Mar 24) to 33.55, marking an increase of 3.33.
- For PBIT / Share (Rs.), as of Mar 25, the value is 24.97. This value is within the healthy range. It has increased from 21.19 (Mar 24) to 24.97, marking an increase of 3.78.
- For PBT / Share (Rs.), as of Mar 25, the value is 33.08. This value is within the healthy range. It has increased from 13.60 (Mar 24) to 33.08, marking an increase of 19.48.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 27.98. This value is within the healthy range. It has increased from 9.66 (Mar 24) to 27.98, marking an increase of 18.32.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 27.97. This value is within the healthy range. It has increased from 9.62 (Mar 24) to 27.97, marking an increase of 18.35.
- For PBDIT Margin (%), as of Mar 25, the value is 9.07. This value is below the healthy minimum of 10. It has increased from 8.72 (Mar 24) to 9.07, marking an increase of 0.35.
- For PBIT Margin (%), as of Mar 25, the value is 6.75. This value is below the healthy minimum of 10. It has increased from 6.11 (Mar 24) to 6.75, marking an increase of 0.64.
- For PBT Margin (%), as of Mar 25, the value is 8.94. This value is below the healthy minimum of 10. It has increased from 3.92 (Mar 24) to 8.94, marking an increase of 5.02.
- For Net Profit Margin (%), as of Mar 25, the value is 7.56. This value is within the healthy range. It has increased from 2.78 (Mar 24) to 7.56, marking an increase of 4.78.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.56. This value is below the healthy minimum of 8. It has increased from 2.77 (Mar 24) to 7.56, marking an increase of 4.79.
- For Return on Networth / Equity (%), as of Mar 25, the value is 22.24. This value is within the healthy range. It has increased from 9.17 (Mar 24) to 22.24, marking an increase of 13.07.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.42. This value is within the healthy range. It has decreased from 19.73 (Mar 24) to 19.42, marking a decrease of 0.31.
- For Return On Assets (%), as of Mar 25, the value is 9.98. This value is within the healthy range. It has increased from 3.19 (Mar 24) to 9.98, marking an increase of 6.79.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.84. This value is within the healthy range. It has decreased from 1.38 (Mar 24) to 0.84, marking a decrease of 0.54.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.27. It has increased from 1.23 (Mar 24) to 1.27, marking an increase of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 1.50. This value is within the healthy range. It has increased from 1.26 (Mar 24) to 1.50, marking an increase of 0.24.
- For Quick Ratio (X), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 1. It has increased from 0.10 (Mar 24) to 0.11, marking an increase of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.70. This value is below the healthy minimum of 4. It has increased from 1.59 (Mar 24) to 1.70, marking an increase of 0.11.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 25.02. This value is within the healthy range. It has decreased from 31.15 (Mar 24) to 25.02, marking a decrease of 6.13.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 19.14. This value is below the healthy minimum of 20. It has increased from 16.06 (Mar 24) to 19.14, marking an increase of 3.08.
- For Earning Retention Ratio (%), as of Mar 25, the value is 74.98. This value exceeds the healthy maximum of 70. It has increased from 68.85 (Mar 24) to 74.98, marking an increase of 6.13.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 80.86. This value exceeds the healthy maximum of 70. It has decreased from 83.94 (Mar 24) to 80.86, marking a decrease of 3.08.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.44. This value is within the healthy range. It has increased from 3.98 (Mar 24) to 4.44, marking an increase of 0.46.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.63. This value is below the healthy minimum of 3. It has increased from 2.27 (Mar 24) to 2.63, marking an increase of 0.36.
- For Enterprise Value (Cr.), as of Mar 25, the value is 732.52. It has decreased from 872.85 (Mar 24) to 732.52, marking a decrease of 140.33.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 0.64 (Mar 24) to 0.50, marking a decrease of 0.14.
- For EV / EBITDA (X), as of Mar 25, the value is 5.58. This value is within the healthy range. It has decreased from 7.38 (Mar 24) to 5.58, marking a decrease of 1.80.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has decreased from 0.24 (Mar 24) to 0.23, marking a decrease of 0.01.
- For Retention Ratios (%), as of Mar 25, the value is 74.97. This value exceeds the healthy maximum of 70. It has increased from 68.84 (Mar 24) to 74.97, marking an increase of 6.13.
- For Price / BV (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has decreased from 0.80 (Mar 24) to 0.68, marking a decrease of 0.12.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has decreased from 0.24 (Mar 24) to 0.23, marking a decrease of 0.01.
- For EarningsYield, as of Mar 25, the value is 0.32. This value is below the healthy minimum of 5. It has increased from 0.11 (Mar 24) to 0.32, marking an increase of 0.21.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mawana Sugars Ltd:
- Net Profit Margin: 7.56%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.42% (Industry Average ROCE: 8.62%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 22.24% (Industry Average ROE: 7.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.63
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.11
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 6 (Industry average Stock P/E: 28.99)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.84
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.56%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Sugar | 5th Floor, Kirti Mahal, New Delhi Delhi 110125 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Krishna Shriram | Chairman & Non-Exe.Director |
| Mr. Rakesh Kumar Gangwar | Managing Director |
| Mr. Mukesh Chauhan | Non Exe.Non Ind.Director |
| Ms. Anuradha Dutt | Ind. Non-Executive Director |
| Mr. Satish Agrawal | Ind. Non-Executive Director |
| Mr. Arun Kumar Kaul | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Mawana Sugars Ltd?
Mawana Sugars Ltd's intrinsic value (as of 27 January 2026) is ₹99.67 which is 27.13% higher the current market price of ₹78.40, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹307 Cr. market cap, FY2025-2026 high/low of ₹112/77.7, reserves of ₹419 Cr, and liabilities of ₹567 Cr.
What is the Market Cap of Mawana Sugars Ltd?
The Market Cap of Mawana Sugars Ltd is 307 Cr..
What is the current Stock Price of Mawana Sugars Ltd as on 27 January 2026?
The current stock price of Mawana Sugars Ltd as on 27 January 2026 is ₹78.4.
What is the High / Low of Mawana Sugars Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Mawana Sugars Ltd stocks is ₹112/77.7.
What is the Stock P/E of Mawana Sugars Ltd?
The Stock P/E of Mawana Sugars Ltd is 6.00.
What is the Book Value of Mawana Sugars Ltd?
The Book Value of Mawana Sugars Ltd is 117.
What is the Dividend Yield of Mawana Sugars Ltd?
The Dividend Yield of Mawana Sugars Ltd is 5.10 %.
What is the ROCE of Mawana Sugars Ltd?
The ROCE of Mawana Sugars Ltd is 10.3 %.
What is the ROE of Mawana Sugars Ltd?
The ROE of Mawana Sugars Ltd is 12.8 %.
What is the Face Value of Mawana Sugars Ltd?
The Face Value of Mawana Sugars Ltd is 10.0.